Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The DNA And Gene Chip Market Size Shifted, And What Is the Outlook Through 2034?
The industry for dna and gene chips has witnessed rapid expansion in the past few years. The market is anticipated to catapult from a valuation of $8.19 billion in 2024 to a staggering $9.2 billion in 2025, marking a compound annual growth rate (CAGR) of 12.2%. The exceptional growth during the historic period can be traced back to developments in genomic research, the surge of personalized medicine, significant achievements in the human genome project, progressive drug discovery and development, and the identification of disease biomarkers.
The market size of dna and gene chip is predicted to experience accelerated expansion in the forthcoming years, reaching a valuation of $15.13 billion in 2029 with a compound annual growth rate (CAGR) of 13.3%. The rising trajectory during the forecast period is expected due to the progression in precision medicine, burgeoning biomarker discovery, the enlargement of individualized therapeutics, its utility in cancer studies, and augmentation in research funding. Notable tendencies during the forecast period involve technological enhancements, innovative products, regulatory structures and adherence, emphasis on rare diseases, and a consistent decrease in expenses.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp
What Are the Core Market Drivers Propelling Growth in the DNA And Gene Chip Industry?
The increasing desire for early detection of cancer is majorly stimulating the expansion of the DNA and gene market. Cancer is a generalized category of diseases that can occur in almost any part of the body when rogue cells multiply uncontrollably, exceed ordinary cellular limitations to infiltrate adjoining organs, and disperse to other body regions. DNA and gene chips aid in evaluating gene expression patterns, identifying the genetic and epigenetic environment, and calculating genomic regulatory ingredients associated with cancer transcription factors in malignant cells. For example, the American Cancer Society, a US-based, community-centric, volunteer health institute, has forecasted that there will be an estimated 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States in 2022. Hence, the escalating need for early detection of cancer is propelling the growth of the DNA and gene chip market.
How Is the DNA And Gene Chip Market Segmented?
The dna and gene chipmarket covered in this report is segmented –
1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users
Subsegments:
1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays
3) By Other Types: Single-Cell RNA Sequencing Chips, SNP (Single Nucleotide Polymorphism) Chips, Whole Genome Amplification Chips
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8205&type=smp
Which Regions Are Driving the Next Phase of the DNA And Gene Chip Market Growth?
North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the DNA And Gene Chip Industry?
The trend of forging strategic alliances and collaborations is fast becoming prevalent in the DNA and gene chip market. Several businesses in this sphere are seeking partnerships as a means to consolidate their presence in this market. For instance, a strategic alliance was established in June 2022 between an Indian company specializing in integrated systems biology platforms, Avesthagen Limited, and an IT firm also from India, Wipro Limited. This collaboration allowed the two companies to carry out a project titled Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer project-related genomics sequencing services. In addition, in May 2022, a partnership was signed between Thermo Fisher Scientific, a US-based manufacturer of analytical instruments, and Qatar Genome Program (QGP), a subsidiary of Qatar Foundation (QF). They together developed an Axiom custom genotyping array for pan-Arab populations, which used whole genome sequencing data from 19 Arab nations. The array, featuring 800,000 variations, aims to improve genomic research concentrated on ailments like diabetes, cardiovascular diseases, autism, and cancer. This partnership furthers Qatar’s national vision of enhancing population health and advancing precision medicine for individuals of Arab origin worldwide. Thermo Fisher’s Axiom microarray technology bolsters the quick implementation of precision medicine initiatives.
View the full report here:
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report
How Is the DNA And Gene Chip Market Defined and What Are Its Core Parameters?
A DNA and gene chip is a microchip that contains microscopic DNA probes attached to a solid surface that can identify DNA from test samples and make up half of the DNA double helix. If the test sample of DNA has the mutation, then the DNA will not bind properly to the sequence on the chip. The DNA and gene chip is used to measure the expression levels of genes or to ascertain whether a particular person’s DNA has mutations in genes which are variations in DNA which can cause ailments.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8205
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model